[A13-23] Addendum to Commission A13-05 (fidaxomicin)
|Commission:||Commission awarded on 2013-05-28 by the Federal Joint Committee (G-BA)|
|Current document:||Addendum to Commission A13-05 (fidaxomicin) Further documents|
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
|Contact address:||to the contact form|
Fidaxomicin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Status: Commission completed
|2013-07-05||Addendum to Commission A13-05 (fidaxomicin)||308 kB|
Federal Joint Committee (G-BA)
2013-07-04 A G-BA decision was published.